More about

Gonorrhea

News
May 28, 2024
2 min read
Save

Questionnaire identifies patients at low risk for penicillin allergy

Questionnaire identifies patients at low risk for penicillin allergy

Researchers found that a questionnaire successfully identified patients with STIs who can be safely evaluated for penicillin allergy by skin test or by a two-step graded oral challenge, according to a study.

News
May 10, 2024
7 min read
Save

Q&A: ‘False sense of safety’ contributes to rise in STDs after menopause

Q&A: ‘False sense of safety’ contributes to rise in STDs after menopause

In the past decade, STDs have increased among women aged at least 55 years, highlighting the importance of discussing sexual partners, sexual history and condom use with all patients, regardless of age.

News
March 12, 2024
1 min read
Save

Top in ID: Doxy-PEP for STI prevention; SARS-CoV-2 antigens active months after infection

Top in ID: Doxy-PEP for STI prevention; SARS-CoV-2 antigens active months after infection

Multiple studies presented at the Conference on Retroviruses and Opportunistic Infections, or CROI, supported doxycycline post-exposure prophylaxis for the prevention of sexually transmitted infections.

News
March 04, 2024
4 min read
Save

New evidence ‘seals the case’ for doxy-PEP as STI prevention tool

New evidence ‘seals the case’ for doxy-PEP as STI prevention tool

DENVER — As clinicians await national guidelines on its use, evidence continues to mount that doxy-PEP can help curtail the prolonged epidemic of sexually transmitted infections in the United States.

News
February 23, 2024
2 min read
Save

Q&A: What does the latest research say about doxycycline prophylaxis for bacterial STIs?

Q&A: What does the latest research say about doxycycline prophylaxis for bacterial STIs?

In recent years, cases of sexually transmitted infections such as chlamydia, gonorrhea and syphilis have been rising in the U.S., affecting all populations and prompting additional prevention efforts.

News
February 13, 2024
2 min read
Save

Top in ID: AI predicts risk for STIs; CDC develops lab testing guideline for syphilis

Top in ID: AI predicts risk for STIs; CDC develops lab testing guideline for syphilis

Researchers developed an artificial intelligence tool that can accurately determine whether a person is at average or high risk for contracting HIV, syphilis, gonorrhea and chlamydia.

News
February 06, 2024
2 min read
Save

Top in ID: Efficacy of updated COVID-19 vaccines; challenges of delivering rural ID care

Top in ID: Efficacy of updated COVID-19 vaccines; challenges of delivering rural ID care

The updated COVID-19 vaccines were 54% effective against symptomatic SARS-CoV-2 infection and offered protection against JN.1 and XBB viral lineages, according to early estimates published by the CDC.

News
February 05, 2024
2 min read
Save

AI tool helps identify patients at high risk for HIV, STIs

AI tool helps identify patients at high risk for HIV, STIs

Using MySTIRisk, an artificial intelligence-based risk assessment tool, researchers were successfully able to create infection risk scores to identify patients at higher risk for HIV, syphilis, gonorrhea and chlamydia.

News
January 30, 2024
3 min read
Save

Gonorrhea cases decline for first time in decade, but syphilis continues to surge

Gonorrhea cases decline for first time in decade, but syphilis continues to surge

Reported cases of gonorrhea in the United States declined for the first time in at least a decade in 2022 while cases of chlamydia remained stagnant and syphilis continued its years-long surge, data released by the CDC on Tuesday showed.

News
December 23, 2023
2 min read
Save

US’s STD epidemic worsened again in 2023

US’s STD epidemic worsened again in 2023

Rates of STDs continue to rise in the United States, with CDC data showing increases year after year.

View more